Zai Lab Limited Share Price Deutsche Boerse AG
Stocks
1ZL
US98887Q1040
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.40 EUR | +0.65% |
|
+6.94% | +5.48% |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 10/06 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| Market Cap | 204.26Cr 178.1Cr 164.94Cr 154.41Cr 289.59Cr 19TCr 291.34Cr 1.96TCr 758.36Cr 9.49TCr 766.74Cr 750.29Cr 33TCr | P/E 2026 * |
-8.21x | P/E 2027 * | -9.75x |
|---|---|---|---|---|---|
| Enterprise Value | 159.95Cr 139.46Cr 129.16Cr 120.91Cr 226.76Cr 15TCr 228.13Cr 1.53TCr 593.84Cr 7.43TCr 600.4Cr 587.52Cr 26TCr | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 2.78x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | +0.65% | ||
| 1 week | +6.94% | ||
| Current month | +1.99% | ||
| 1 month | -1.91% | ||
| 3 months | -1.91% | ||
| 6 months | +4.76% | ||
| Current year | +5.48% |
| 1 week | 14.6 |  | 15.4 |
| 1 month | 13.6 | | 15.8 |
| Current year | 13.2 | | 21 |
| 1 year | 13.2 | | 34.2 |
| 3 years | 12.4 | | 38.2 |
| 5 years | 12.4 | | 148 |
| 10 years | 12.4 | | 162 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 60 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 60 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 82 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 74 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.65% | +6.94% | - | - | 204.26Cr | |
| +0.33% | -0.36% | +18.76% | -22.11% | 6.21TCr | |
| +0.20% | -9.17% | +58.39% | +196.56% | 5.45TCr | |
| -3.92% | +37.40% | +37.40% | +37.40% | 4.15TCr | |
| +7.62% | +8.19% | -51.27% | -59.11% | 3.91TCr | |
| -1.05% | -1.73% | +55.35% | -33.92% | 2.9TCr | |
| +3.50% | +28.15% | +151.81% | -50.31% | 2.54TCr | |
| -0.78% | -9.50% | +43.87% | +55.34% | 1.96TCr | |
| +1.74% | -0.39% | -2.93% | +113.90% | 1.69TCr | |
| -0.05% | +0.23% | +61.48% | +101.93% | 1.59TCr | |
| Average | +0.82% | +2.77% | +41.43% | +37.74% | 3.38TCr | |
| Weighted average by Cap. | +0.78% | +1.72% | +36.67% | +36.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 39Cr 36Cr 34Cr 64Cr 4.23TCr 64Cr 429.84Cr 166.59Cr 2.08TCr 168.43Cr 164.81Cr 7.24TCr | 60Cr 52Cr 48Cr 45Cr 84Cr 5.62TCr 85Cr 570.55Cr 221.12Cr 2.77TCr 223.56Cr 218.77Cr 9.6TCr |
| Net income | -24Cr -21Cr -19Cr -18Cr -34Cr -2.27TCr -34Cr -230.77Cr -89Cr -1.12TCr -90Cr -88Cr -3.88TCr | -16Cr -14Cr -13Cr -12Cr -22Cr -1.48TCr -22Cr -149.89Cr -58Cr -726.71Cr -59Cr -57Cr -2.52TCr |
| Net Debt | -44Cr -39Cr -36Cr -33Cr -63Cr -4.18TCr -63Cr -424.51Cr -164.52Cr -2.06TCr -166.34Cr -162.77Cr -7.15TCr | -39Cr -34Cr -31Cr -29Cr -55Cr -3.65TCr -55Cr -370.92Cr -143.75Cr -1.8TCr -145.34Cr -142.22Cr -6.24TCr |
| Date | Price | Change |
|---|---|---|
| 19/26/19 | 15.40 € | +0.65% |
| 18/26/18 | 15.30 € | +4.08% |
| 17/26/17 | 14.70 € | -1.34% |
| 16/26/16 | 14.90 € | +2.05% |
| 15/26/15 | 14.60 € | +1.39% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- 1ZL Stock
Select your edition
All financial news and data tailored to specific country editions
